SPOT

ETFs like AWAY are riding on "funflation" as consumers keep spending on hobbies, travel, music and leisure despite higher prices.

Neko Health, a Spotify founder's preventative-health startup, opened its first U.S. clinic. Plus, chemicals in natural-fiber clothing and the real culprit for childhood anxiety.

Recently, Zacks.com users have been paying close attention to Spotify (SPOT). This makes it worthwhile to examine what the stock has in store.

Spotify Technology S.A. (NYSE:SPOT) was last seen down 0.2% at $500.39, inching toward its fifth loss in the last six sessions. Furthermore, SPOT's most recent downturn has it crossing below the 200-day moving average, a familiar trendline of pressure.

Spotify is giving listeners a new tool to shape the recommendations it delivers to their app's Home feed.

Spotify's Q2 gross margin rose to 33.4% as Premium growth outpaced music costs and Ad-Supported gains lifted operating profitability.

Bank of America is standing firmly behind streaming giant Spotify Technology SA (NYSE:SPOT) despite a rough week for the stock. In a note Friday, the bank reiterated its Buy rating and $685 price target, pushing back against any narrative that the company's growth story is faltering.

Investors interested in Internet - Software stocks are likely familiar with Digital Turbine (APPS) and Spotify (SPOT). But which of these two stocks offers value investors a better bang for their buck right now?

Spotify Technology NYSE: SPOT Co-CEO, Chief Product Officer and Chief Technology Officer Gustav Söderström outlined the company's strategy for using artificial intelligence, expanding into additional media formats and monetizing highly engaged users during an investor conference appearance.

Zacks.com users have recently been watching Spotify (SPOT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.